Radioimmunotherapy with radioactive nanoparticles: Biological doses and treatment efficiency for vascularized tumors with or without a central hypoxic area

The Advantages of Nanoparticles for PET

(2009) M. J. Welch et al.   JOURNAL OF NUCLEAR MEDICINE

The small-molecule CDK inhibitor, SNS-032, enhances cellular radiosensitivity in quiescent and hypoxic non-small cell lung cancer cells

(2009) Elisabeth Kodym et al.   LUNG CANCER

Use of antibodies and immunoconjugates for the therapy of more accessible cancers

(2008) Robert M. Sharkey et al.   ADVANCED DRUG DELIVERY REVIEWS

Toward theragnostics

(2008) Frédéric Pene et al.   CRITICAL CARE MEDICINE

Apoferritin-Templated Yttrium Phosphate Nanoparticle Conjugates for Radioimmunotherapy of Cancers

(2008) Hong Wu et al.   JOURNAL OF NANOSCIENCE AND NANOTECHNOLOGY

Extension of the biological effective dose to the MIRD schema and possible implications in radionuclide therapy dosimetry

(2008) Sébastien Baechler et al.   MEDICAL PHYSICS

Some implications of linear-quadratic-linear radiation dose-response with regard to hypofractionation

(2008) Melvin Astrahan   MEDICAL PHYSICS

Determination of biological vector characteristics and nanoparticle dimensions for radioimmunotherapy with radioactive nanoparticles

(2007) V.E. Nuttens et al.   APPLIED RADIATION AND ISOTOPES